Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment

Launched by EYE & ENT HOSPITAL OF FUDAN UNIVERSITY · Sep 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical methods to treat a specific type of eye condition called rhegmatogenous retinal detachment (RRD), which happens when there are tears in the retina that can lead to vision loss. The trial aims to compare a new technique using a foldable capsular scleral buckle (FCSB) with a standard procedure called vitrectomy, to see which method is safer and more effective for patients with medium-complexity retinal detachments.

To be eligible for the trial, participants should have one or more retinal holes that are too large or complex to be treated with a simple silicone sponge or band. However, those with simpler forms of retinal detachment or other serious eye conditions, like severe cataracts, will not be included. If you qualify and decide to participate, you can expect to undergo one of the two surgical procedures and will be monitored for safety and effectiveness. This trial is not yet recruiting patients, but it’s important to know that it aims to improve treatment options for people facing this eye condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • One or more retinal holes which cannot be treated sufficiently with a single silicon sponge or silicone band (e.g. large holes, multiple holes, multiple holes of varying anterior-posterior localisation, massive traction)
• • Exclusion Criteria
• • 1. simple rhegmatogenous retinal detachment which can be treated with a single silicon sponge or silicone band (e.g. single holes, no traction, limit retinal detachment)
• • 2. Complicated RRD, including macular hole within the arcade, PVR C or D, severe cataract, severe vitreous hemorrhage, unclear macular hole,
• • 3. Combined with other eye diseases that affect vision prognosis.
• • 4. History of other eye surgeries including cataract surgery.
• • 5. Presence of systemic diseases that may affect postoperative observation and follow-up.